Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Cipher Pharmaceuticals Inc T.CPH

Alternate Symbol(s):  CPHRF

Cipher Pharmaceuticals Inc. is a specialty pharmaceutical company with a diversified portfolio of commercial and early to late-stage products, mainly in dermatology. The Company acquires products that fulfill unmet medical needs, manages the required clinical development and regulatory approval process, and markets those products in Canada, the United States, and South America. Its dermatology products include Actikerall, Epuris, and Vaniqa. Its hospital acute care products include Aggrastat and Brinavess. Its out-licensed products include Absorica, ConZip and Lipofen. Durela is its specialty medicine. Its product pipeline includes MOB-015, CF-101, and DTR-001. It delivers novel products to healthcare professionals and patients in Canada in a range of therapeutic areas, including dermatology, women’s health, urology and others. It also has the Natroba operations and global product rights to Natroba and its authorized generic Spinosad, a topical treatment for both head lice and scabies.


TSX:CPH - Post by User

Bullboard Posts
Comment by Stylesson Jul 16, 2015 11:23am
99 Views
Post# 23929952

RE:RE:RE:RE:RE:RE:LIKE I KEEP SAYING...

RE:RE:RE:RE:RE:RE:LIKE I KEEP SAYING...
of course market manipulation happens. But you sound like a guy who understands the theory, but has never executed. It's very difficult to manipulate a stock like CPH given the lack of liquidity. You can't really short it because it's too expensive/illiquid and there's no real borrow.

You talk a big game, but you don't know what you're talking about.

There's no manipulation going on with this stock. It's trending lower because a few guys are long a million shares and want off. What happens when you want off a position and a stock only trades a few thousand dollars a day. You got to dump it and take the price lower.
There's no real buyers of CPH out there. That's the real problem.

Don't overcomplicate things.


Bullboard Posts